Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 11, 2015, Pages 2617-2632

  Yu, Fujun ^a   Lu, Zhongqiu ^a   Chen, Bicheng ^a   Wu, Xiaoli ^a   Dong, Peihong ^a   Zheng, Jianjian ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; DNA methyltransferase; Hepatic stellate cells; MicroRNA 152; Patched1

Indexed keywords

DNA METHYLTRANSFERASE 1; MICRORNA; MICRORNA 152; PROTEIN PATCHED 1; SALVIANOLIC ACID B; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; BENZOFURAN DERIVATIVE; DMAP1 PROTEIN, MOUSE; MIRN152 MICRORNA, MOUSE; PTCH1 PROTEIN, MOUSE; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LUCIFERASE ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; LIVER CIRRHOSIS; METABOLISM; METHYLATION; MOUSE;

ANIMALS; BENZOFURANS; EPIGENESIS, GENETIC; LIVER CIRRHOSIS; METHYLATION; MICE; MICRORNAS; PATCHED-1 RECEPTOR; REPRESSOR PROTEINS;

EID: 84945492192     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12655     Document Type: Article

References (40)

1. Kong X, Horiguchi N, Mori M, et al. Cytokines and STATs in liver fibrosis. Front Physiol. 2012; 3: 69.
2. Kwiecinski M, Noetel A, Elfimova N, et al. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS ONE. 2011; 6: e24568.
3. He Y, Huang C, Zhang SP, et al. The potential of microRNAs in liver fibrosis. Cell Signal. 2012; 24: 2268-72.
4. Lee JM, Dedhar S, Kalluri R, et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006; 172: 973-81.
5. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000; 275: 2247-50.
6. Choi SS, Syn WK, Karaca GF, et al. Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem. 2010; 285: 36551-60.
7. Lin YL, Wu CH, Luo MH, et al. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol. 2006; 105: 215-22.
8. Liu P, Hu YY, Liu C, et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol. 2002; 8: 679-85.
9. Wang XN, Hu YY, Liu CH, et al. Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis. Zhong Xi Yi Jie He Xue Bao. 2005; 3: 286-9.
10. Choi SS, Omenetti A, Witek RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2009; 297: G1093-106.
11. Zuo Y, Song Y, Zhang M, et al. Role of PTCH1 gene methylation in gastric carcinogenesis. Oncol Lett. 2014; 8: 679-82.
12. Yang JJ, Tao H, Huang C, et al. DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis. Cell Signal. 2013; 25: 1202-11.
13. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005; 74: 481-514.
14. Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev. 2005; 15: 163-76.
15. Sun X, He Y, Ma TT, et al. Participation of miR-200a in TGF-beta1-mediated hepatic stellate cell activation. Mol Cell Biochem. 2014; 388: 11-23.
16. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9: 102-14.
17. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
18. Noetel A, Kwiecinski M, Elfimova N, et al. microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol. 2012; 3: 49.
19. Yu F, Guo Y, Chen B, et al. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest. 2015; 95: 781-9.
20. Sekiya Y, Ogawa T, Yoshizato K, et al. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011; 412: 74-9.
21. Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009; 113: 6411-8.
22. Zheng J, Wu C, Lin Z, et al. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation-a novel mechanism suppressing liver fibrosis. FEBS J. 2014; 281: 88-103.
23. Uyama N, Zhao L, Van Rossen E, et al. Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut. 2006; 55: 1276-89.
24. Tao YY, Wang QL, Shen L, et al. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. Exp Biol Med. 2013; 238: 1284-96.
25. Liu J, Zhang Z, Tu X, et al. Knockdown of N-acetylglucosaminyl transferase V ameliorates hepatotoxin-induced liver fibrosis in mice. Toxicol Sci. 2013; 135: 144-55.
26. Wang P, Xu S, Li W, et al. Salvianolic acid B inhibited PPARgamma expression and attenuated weight gain in mice with high-fat diet-induced obesity. Cell Physiol Biochem. 2014; 34: 288-98.
27. Bai Y, Lu H, Zhang G, et al. Sedum sarmentosum Bunge extract exerts renal anti-fibrotic effects in vivo and in vitro. Life Sci. 2014; 105: 22-30.
28. Feng Z, Guo W, Zhang C, et al. CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma. PLoS ONE. 2011; 6: e26399.
29. Chen T, Wang C, Wu F, et al. Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma. PLoS ONE. 2015; 10: e0118645.
30. Bai Y, Lu H, Wu C, et al. Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway. Biochem Pharmacol. 2014; 92: 484-93.
31. Chen KC, Wang YS, Hu CY, et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 2011; 25: 1718-28.
32. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3: 1101-8.
33. Ji W, Yang L, Yu L, et al. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis. 2008; 29: 1267-75.
34. Omenetti A, Porrello A, Jung Y, et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest. 2008; 118: 3331-42.
35. Sicklick JK, Li YX, Choi SS, et al. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest. 2005; 85: 1368-80.
36. Yang L, Wang Y, Mao H, et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol. 2008; 48: 98-106.
37. Li S, Wang L, Yan X, et al. Salvianolic acid B attenuates rat hepatic fibrosis via downregulating angiotensin II signaling. Evid Based Complement Alternat Med. 2012; 2012: 160726.
38. Wang QL, Tao YY, Yuan JL, et al. Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro. BMC Cell Biol. 2010; 11: 31.
39. Huang H, Hu M, Li P, et al. Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT. Tumour Biol. 2015; 36: 921-8.
40. Huang S, Xie Y, Yang P, et al. HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells. PLoS ONE. 2014; 9: e81730.